Danaher Co. (NYSE:DHR) Stock Holdings Lifted by SRS Capital Advisors Inc.

SRS Capital Advisors Inc. raised its position in shares of Danaher Co. (NYSE:DHR) by 3.3% in the fourth quarter, Holdings Channel reports. The firm owned 7,829 shares of the conglomerate’s stock after buying an additional 250 shares during the period. SRS Capital Advisors Inc.’s holdings in Danaher were worth $1,811,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the company. Nicholas Hoffman & Company LLC. raised its holdings in shares of Danaher by 2.3% in the fourth quarter. Nicholas Hoffman & Company LLC. now owns 1,899 shares of the conglomerate’s stock valued at $439,000 after purchasing an additional 43 shares during the last quarter. Los Angeles Capital Management LLC lifted its position in Danaher by 1.3% during the 4th quarter. Los Angeles Capital Management LLC now owns 3,470 shares of the conglomerate’s stock worth $803,000 after buying an additional 43 shares in the last quarter. Drive Wealth Management LLC boosted its stake in shares of Danaher by 3.1% during the 4th quarter. Drive Wealth Management LLC now owns 1,485 shares of the conglomerate’s stock worth $344,000 after buying an additional 44 shares during the last quarter. Mission Wealth Management LP raised its holdings in Danaher by 0.4% during the fourth quarter. Mission Wealth Management LP now owns 10,888 shares of the conglomerate’s stock worth $2,519,000 after acquiring an additional 46 shares in the last quarter. Finally, Trust Investment Advisors boosted its holdings in shares of Danaher by 1.8% in the 4th quarter. Trust Investment Advisors now owns 2,811 shares of the conglomerate’s stock valued at $650,000 after buying an additional 49 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Danaher

In other news, CEO Rainer Blair sold 47,175 shares of Danaher stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $249.22, for a total value of $11,756,953.50. Following the transaction, the chief executive officer now owns 115,995 shares in the company, valued at approximately $28,908,273.90. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In related news, CEO Rainer Blair sold 47,175 shares of Danaher stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $249.22, for a total transaction of $11,756,953.50. Following the sale, the chief executive officer now directly owns 115,995 shares of the company’s stock, valued at approximately $28,908,273.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Georgeann Couchara sold 2,622 shares of the stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $242.67, for a total transaction of $636,280.74. Following the completion of the transaction, the senior vice president now directly owns 4,244 shares of the company’s stock, valued at approximately $1,029,891.48. The disclosure for this sale can be found here. Insiders sold a total of 106,565 shares of company stock worth $26,641,364 over the last three months. Corporate insiders own 11.10% of the company’s stock.

Danaher Price Performance

NYSE:DHR traded down $0.69 during trading hours on Thursday, reaching $246.20. 1,023,314 shares of the company were exchanged, compared to its average volume of 2,758,876. The company has a market capitalization of $182.36 billion, a P/E ratio of 41.85, a P/E/G ratio of 3.80 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.85 and a quick ratio of 1.51. The business has a 50 day moving average of $248.71 and a 200 day moving average of $231.90. Danaher Co. has a 1-year low of $182.09 and a 1-year high of $259.00.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.20. The company had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.62 billion. Danaher had a return on equity of 11.43% and a net margin of 16.78%. Danaher’s revenue was down 2.6% on a year-over-year basis. During the same quarter last year, the business earned $2.36 earnings per share. Research analysts forecast that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 26th. Investors of record on Thursday, March 28th were paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. This is a boost from Danaher’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend was Wednesday, March 27th. Danaher’s dividend payout ratio (DPR) is 18.31%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. KeyCorp boosted their target price on shares of Danaher from $260.00 to $290.00 and gave the stock an “overweight” rating in a report on Thursday, February 1st. Raymond James boosted their price target on Danaher from $240.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 31st. TD Cowen lifted their target price on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a research note on Wednesday, April 24th. StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a research note on Wednesday, January 31st. Finally, Bank of America lifted their price objective on shares of Danaher from $258.00 to $270.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 24th. Six research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $267.31.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.